Taratingan, John .
HRN: 24-45-15 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/06/2025
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
02/06/2025
02/13/2025
IV
350mg
Q6h
Pneumonia
Checking Final Appropriateness
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes